In this downloadable slideset, Farhad Ravandi, MD, provides expert insights on key clinical biomarkers for prognostication and individualizing treatment for patients with AML.
In this downloadable slideset, Farhad Ravandi, MD, reviews current and investigational uses of immunotherapy for patients with AML.
In this downloadable slideset, Eytan M. Stein, MD, provides expert insights and guidance on individualizing treatment for patients with AML with FLT3 or IDH1/2 mutations.
In this downloadable slideset, Ellen K. Ritchie, MD, spotlights targeted therapies and other agents in clinical development for patients with AML.
In this downloadable slideset, Ellen K. Ritchie, MD, provides expert insights and guidance on individualizing treatment for patients with newly diagnosed AML.
Watch this on-demand Webcast from the CCO AML satellite at ASCO 2019, featuring expert discussion on key clinical biomarkers; new antibody-based therapies; treatment strategies for newly diagnosed AML and AML positive for IDH or FLT3 mutations; and emerging molecular targets.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.